The costs of treating hypertension in Sweden. An empirical investigation in primary health care.

No abstract is available for this paper.

• Publication year

  1991

• Venue

  Scandinavian Journal of Primary Health Care

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Economics

• Identifiers
  DOI 10.3109/02813439109018511PMID 1754746
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Diffusion of medical devices in primary health care in Sweden

  1989cited by this paper
• Cost‐Effectiveness of a Worksite Hypertension Treatment Program

  1981cited by this paper
• Hypertension: A Policy Perspective

  1976cited by this paper
• Statistisk årsbok för Sverige = Statistical yearbook of Sweden

  year unknowncited by this paper

• Economic impact of steroid-induced comorbidities in severe asthma: a SHARP CRC simulation

  2025cites this paper
• Cost-effectiveness of an indicated preventive intervention for depression in adolescents: a model to support decision making.

  2020cites this paper
• A geospatial model to determine the spatial cost-efficiency of anticoagulation drug therapy: Patients' perspective.

  2019cites this paper
• A Cost-Effectiveness Analysis of the Swedish Universal Parenting Program All Children in Focus

  2015cites this paper
• Badania farmakoekonomiczne - subiektywna ocena jakości życia oraz analiza kosztów leczenia nadciśnienia tętniczego w Polsce

  2014cites this paper
• Maxillary sinus augmentation with iliac autograft - a health-economic analysis.

  2013cites this paper
• Economic burden of moderate to severe plaque psoriasis in Canada

  2012cites this paper
• Pharmacoeconomic Considerations in the Management of Hypertension

  2012cites this paper
• COST ANALYSIS AND POLICY IMPLICATIONS IN PSYCHIATRIC CARE

  2009cites this paper
• Physical activity on prescription (PAP): Costs and consequences of a randomized, controlled trial in primary healthcare

  2009cites this paper
• Cost-effectiveness of antihypertensive treatment in Malaysia.

  2009cites this paper
• A multinational investigation of time and traveling costs in attending anticoagulation clinics.

  2008cites this paper
• Health economics of depression

  2006cites this paper
• Rehabilitation of elderly with coronary heart disease – Improvement in quality of life at a low cost

  2005cites this paper
• Health economy of the metabolic syndrome pandemic

  2005cites this paper
• Health economics in the Hypertension Optimal Treatment (HOT) study: costs and cost‐effectiveness of intensive blood pressure lowering and low‐dose aspirin in patients with hypertension

  2003cites this paper
• Burden of illness of Crohn's disease in Spain.

  2003cites this paper
• The PANDORA project: results of the cost of illness analysis

  2001cites this paper
• Current Research in Hypertension — the Swedish Experiences

  2000cites this paper
• [Costs analysis of ambulatory blood pressure monitoring in mild hypertension].

  1999cites this paper
• Análisis de costes de la monitorización ambulatoria de la presión arterial en hipertensión leve

  1999cites this paper
• Treatment of benign prostatic hyperplasia and hypertension in elderly hypertensive patients.

  1998cites this paper
• Treating hypertension. Are the right drugs given to the right patients?

  1998cites this paper
• Starting insulin therapy in elderly non-insulin-dependent diabetic patients at a health care centre. Methodological and economic aspects.

  1997cites this paper
• The effect of treating people with reversible ischaemic attacks of the brain and eye on the incidence of stroke in Australia.

  1997cites this paper
• Incorporating Future Costs in Medical Cost-Effectiveness Analysis

  1997cites this paper
• DOXAZOSIN: A NEW APPROACH TO HYPERTENSION AND BENIGN PROSTATIC HYPERPLASIA

  1996cites this paper
• Cost-effectiveness of fracture prevention in established osteoporosis.

  1996cites this paper
• The cost effectiveness of lipid lowering in Swedish primary health care

  1996cites this paper
• The Costs of Antihypertensive Therapy-Reply

  1996cites this paper
• The Estimation of Costs

  1996cites this paper
• The Cost of Angina Pectoris in Sweden

  1995cites this paper
• Treatment preferences, return visit planning and factors affecting hypertension practice amongst general practitioners and internal medicine specialists (The General Practitioner Hypertension Practice Study)

  1995cites this paper
• The costs and effects of two different lipid intervention programmes in primary health care

  1995cites this paper
• The Cost Effectiveness of Hypertension Treatment in Sweden

  1995cites this paper
• Defining the Patient Group for Cost-Effective Withdrawal of Antihypertensive Therapy

  1995cites this paper
• Selective versus nonselective beta adrenoceptor antagonists in hypertension.

  1995cites this paper
• Selective versus Nonselective β Adrenoceptor Antagonists in Hypertension

  1995cites this paper
• Cost-effectiveness of fracture prevention in established osteoporosis

  1995cites this paper
• The cost‐effectiveness of a cardiovascular multiple‐risk‐factor intervention programme in treated hypertensive men

  1995cites this paper
• Effectiveness and Costs of Veterans Affairs Hypertension Clinics

  1994cites this paper
• The Impact of Age on the Cost - Effectiveness of Hypertension Treatment

  1994cites this paper
• Enalapril

  1994cites this paper
• The cost-effectiveness of the switch towards more expensive antihypertensive drugs.

  1994cites this paper
• Enalapril: a review of quality-of-life and pharmacoeconomic aspects of its use in heart failure and mild to moderate hypertension.

  1994cites this paper
• Cardiovascular risk factors in treated hypertensives—a nation‐wide, cross‐sectional study in Sweden

  1993cites this paper
• The cost of screening for hypercholesterolaemia--results from a clinical trial in Swedish primary health care.

  1993cites this paper
• Drug Expenditure and New Drug Introductions

  1993cites this paper
• Drug expenditure and new drug introductions: the Swedish experience.

  1993cites this paper
• The cost‐effectiveness of treating hypertension in elderly people—an analysis of the Swedish Trial in Old Patients with Hypertension (STOP Hypertension)

  1993cites this paper
• Economic Evaluation of Hypertension Treatment

  1992cites this paper
• A Review of Cost-Effectiveness Analyses of Hypertension Treatment

  1992cites this paper
• The costs of treating hypertension--an analysis of different cut-off points.

  1991cites this paper
• Cost‐benefit analysis of non‐pharmacological treatment of hypertension

  1991cites this paper
• Cost-effectiveness analysis of hypertension treatment--a review of methodological issues.

  1991cites this paper